AvantBio’s (AvantFluor’s) patent applications regarding its new Sulfur Fluoride production processes have been granted in the Russian Federation, Mexico, Australia and South Africa. Dr. Rolf Winter (Inventor, VP and Director of Chemistry Research) and Dr. Paul W. Cook (President and CSO) anticipate that the these granted patents represent a harbinger of future patent protection for AvantBio’s [...]

Using its novel defined animal / human origin-free cell (dAOF) cell culture supplement platform, AvantBio now reports that it has successfully adapted its proprietary dAOF culture system for the efficient propagation of both human dermal fibroblasts (HDF) and human corneal fibroblasts (Keratocytes). AvantBio’s new dAOF supplement system performs favorably when compared to supplements which utilize [...]

A division of the AvantBio Corporation, AvantFluor has developed new patent-pending processes for the improved synthesis of sulfur fluorides (SF5Br, SF5Cl and SF4) for the production of deoxofluorine organic derivatives and SF5-bearing organics. MORE INFO